Literature DB >> 1721625

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

C L Gladson1, D A Cheresh.   

Abstract

Glioblastoma multiforme, the most malignant astroglial-derived tumor, grows as an adherent mass and locally invades normal brain. An examination of adult cerebral glioblastoma biopsy material for the expression of adhesive proteins that might potentiate adhesion and invasion demonstrated tumor cell-associated vitronectin (5/5). In contrast, vitronectin was not detected associated with glial cells in low grade astroglial tumors (0/4), reactive astrogliosis (0/4), or in normal adult cortex and cerebral white matter (0/5). Also, a wide variety of other adhesive ligands were absent from the glioblastoma tumor parenchyma. The alpha v beta 3 integrin was the only vitronectin receptor identified in glioblastoma tumors in situ, and was also not expressed on low grade astroglial-derived tumors, reactive astrogliosis, or on glia or neurons in normal adult cortex and cerebral white matter. In a cell attachment assay, cultured glioblastoma cells attached to the parenchyma of glioblastoma tumor cryostat sections at the sites of vitronectin expression, but failed to attach to normal brain. This adhesion was inhibited by antibodies directed against vitronectin, the alpha v beta 3 integrin, and with an Arg-Gly-Asp-containing peptide. These data provide evidence for a cell adhesion mechanism in glioblastoma tumors that might potentiate glioblastoma cell invasion of normal brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721625      PMCID: PMC295768          DOI: 10.1172/JCI115516

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

Review 1.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.

Authors:  E M Salonen; A Vaheri; J Pöllänen; R Stephens; P Andreasen; M Mayer; K Danø; J Gailit; E Ruoslahti
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

3.  Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue.

Authors:  J T Reilly; J R Nash
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

4.  Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas.

Authors:  T R Jones; E Ruoslahti; S C Schold; D D Bigner
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

5.  Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall.

Authors:  F Niculescu; H G Rus; D Poruţiu; V Ghiurca; R Vlaicu
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

6.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.

Authors:  S M Albelda; S A Mette; D E Elder; R Stewart; L Damjanovich; M Herlyn; C A Buck
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

7.  Vitronectin and thrombospondin promote retinal neurite outgrowth: developmental regulation and role of integrins.

Authors:  K M Neugebauer; C J Emmett; K A Venstrom; L F Reichardt
Journal:  Neuron       Date:  1991-03       Impact factor: 17.173

8.  A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin.

Authors:  R Pytela; M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Comparative distribution of fibronectin and vitronectin in human breast and colon carcinomas. An immunofluorescence study.

Authors:  B Loridon-Rosa; P Vielh; C Cuadrado; P Burtin
Journal:  Am J Clin Pathol       Date:  1988-07       Impact factor: 2.493

10.  Immunolocalization of laminin in neoplasms of the central and peripheral nervous systems.

Authors:  R D McComb; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1985-05       Impact factor: 3.685

View more
  114 in total

1.  Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.

Authors:  C L Gladson; C Dennis; T C Rotolo; D R Kelly; J R Grammer
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Blocking IKKα expression inhibits prostate cancer invasiveness.

Authors:  Rubi Mahato; Bin Qin; Kun Cheng
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

4.  A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.

Authors:  Xishan Chen; Lingyu Tai; Jie Gao; Jianchang Qian; Mingfei Zhang; Beibei Li; Cao Xie; Linwei Lu; Wuyuan Lu; Weiyue Lu
Journal:  J Control Release       Date:  2015-09-30       Impact factor: 9.776

5.  Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.

Authors:  Young-Seung Kim; Yang Zhou; Henry Bryant; Diane E Milenic; Kwamena E Baidoo; Bobbi K Lewis; Joseph A Frank; Martin W Brechbiel
Journal:  Bioorg Med Chem Lett       Date:  2015-04-04       Impact factor: 2.823

Review 6.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 7.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Authors:  Michal Reichert
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

9.  Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Authors:  Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David Tice; Anil K Sood
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

10.  Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

Authors:  L Burt Nabors; Tom Mikkelsen; Steven S Rosenfeld; Fred Hochberg; Narasimha S Akella; Joy D Fisher; Gretchen A Cloud; Yu Zhang; Kathryn Carson; Sabine M Wittemer; A Dimitrios Colevas; Stuart A Grossman
Journal:  J Clin Oncol       Date:  2007-05-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.